» Articles » PMID: 30693104

Hematological Abnormalities of Pulmonary Tuberculosis Patients with and Without HIV at the University of Gondar Hospital, Northwest Ethiopia: A Comparative Cross-Sectional Study

Overview
Publisher Wiley
Date 2019 Jan 30
PMID 30693104
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hematological abnormalities are common in pulmonary tuberculosis (PTB) patients, which is one of the major public health problems worldwide. However, there is paucity of information about the hematological profile of PTB patients with and without HIV in the study area. Therefore, this study aimed to assess hematological abnormalities of pulmonary tuberculosis patients with and without HIV at the University of Gondar Hospital, Northwest Ethiopia.

Methods: A comparative cross-sectional study was conducted at the University of Gondar Hospital. Sociodemographic data was collected using a pretested, structured questionnaire. Five milliliters of venous blood sample was collected and divided into a 3 ml EDTA tube for complete blood count with the Cell Dyn 1800 hematological analyzer and a 2 ml citrated tube for erythrocyte sedimentation rate determination. Data were entered into Epi Info version 3.5.3 and then transferred to SPSS 20 for analysis. The independent samples -test was used to compare the mean values of hematological parameters between PTB patients and PTB-HIV coinfected patients.

Result: A total of 100 study subjects (50 PTB and 50 PTB-HIV coinfected) were included with a mean age of 31.3 ± 10.3 years for PTB patients and 32.1 ± 9.2 years for PTB-HIV coinfected patients. In this study, there were significantly lower mean values of Hgb ( = 0.049), platelet count ( < 0.001), and neutrophils counts ( = 0.007) among PTB-HIV coinfected patients when compared with PTB patients. Of the PTB infected patients 46% were anemic, 6% leukopenic, 22% neutropenic, 8% lymphopenic, and 8% thrombocytopenic. On the other hand, of the PTB-HIV coinfected patients 60% were anemic, 14% leukopenic, 66% neutropenic, 12% lymphopenic, and 20% thrombocytopenic. ESR value was increased in all patients.

Conclusion: This study demonstrated high prevalence of neutropenia, anemia, and thrombocytopenia among PTB-HIV coinfected patients. HIV coinfection worsens hematological abnormalities of PTB patients. Assessment of hematological parameters can be used as an indicator in the diagnosis and follow-up of PTB patients coinfected with HIV. We recommended assessment of PTB patients with or without HIV for various hematological disorders such as neutropenia, anemia, and thrombocytopenia.

Citing Articles

Association of Altered Baseline Hematological Parameters with Adverse Tuberculosis Treatment Outcomes.

Nancy Pandiarajan A, Kumar N, Moideen K, Thiruvengadam K, Hissar S, Sivakumar S Pathogens. 2025; 14(2).

PMID: 40005523 PMC: 11857862. DOI: 10.3390/pathogens14020146.


Haematological markers as predictive tools for tuberculosis in PLHIV: a retrospective cohort study in Gujarat, India.

M Y, Vamja R, Parmar P, Makwana N, Sundar R BMC Infect Dis. 2025; 25(1):228.

PMID: 39962402 PMC: 11834239. DOI: 10.1186/s12879-025-10625-y.


Longitudinal mitochondrial bioenergetic signatures of blood monocytes and lymphocytes improve during treatment of drug-susceptible pulmonary tuberculosis patients Monocyte/lymphocyte bioenergetic signatures post-TB treatment.

Cumming B, Addicott K, Maruri F, Pillay V, Asmal R, Moodley S Front Immunol. 2024; 15:1465448.

PMID: 39606220 PMC: 11599235. DOI: 10.3389/fimmu.2024.1465448.


A qualitative study to inform the development of a decision support tool for the diagnosis of pulmonary tuberculosis in Tigray, Ethiopia.

Gebregergs G, Berhe G, Gebrehiwot K, Mulugeta A BMC Med Inform Decis Mak. 2024; 24(1):338.

PMID: 39543601 PMC: 11566201. DOI: 10.1186/s12911-024-02765-z.


Joint clinical determinants for bivariate hematological parameter among TB/HIV co-infected adults under TB/HIV treatment in university of Gondar comprehensive specialized hospital: Retrospective panel data study.

Muhie N BMC Res Notes. 2024; 17(1):150.

PMID: 38824610 PMC: 11143627. DOI: 10.1186/s13104-024-06808-6.


References
1.
Singh K, Ahluwalia G, Sharma S, Saxena R, Chaudhary V, Anant M . Significance of haematological manifestations in patients with tuberculosis. J Assoc Physicians India. 2002; 49:788, 790-4. View

2.
Viallard J, Parrens M, Boiron J, Texier J, Mercie P, Pellegrin J . Reversible myelofibrosis induced by tuberculosis. Clin Infect Dis. 2002; 34(12):1641-3. DOI: 10.1086/340524. View

3.
Killewo J . Poverty, TB, and HIV infection: a vicious cycle. J Health Popul Nutr. 2003; 20(4):281-4. View

4.
Paton N, Ng Y, Chee C, Persaud C, Jackson A . Effects of tuberculosis and HIV infection on whole-body protein metabolism during feeding, measured by the [15N]glycine method. Am J Clin Nutr. 2003; 78(2):319-25. DOI: 10.1093/ajcn/78.2.319. View

5.
Williams N, Bertoncello I, Jackson H, Arnold J, Kavnoudias H . The role of interleukin 6 in megakaryocyte formation, megakaryocyte development and platelet production. Ciba Found Symp. 1992; 167:160-70; discussion 170-3. DOI: 10.1002/9780470514269.ch10. View